Abstract

Accurate detection and characterization of biomarkers on the cell surface play a crucial role in the diagnosis and treatment of various cancers. This study focuses on the multiplex detection of key biomarkers including Estrogen Receptor (ER), Progesterone Receptor (PR), Human Epidermal Growth Factor Receptor 2 (HER2), Cancer Antigen 15-3 (CA 15-3), Cancer Antigen 27.29 (CA 27.29), and Carcinoembryonic Antigen (CEA) in cancer samples. A comprehensive approach utilizing advanced molecular techniques is employed to simultaneously assess the expression levels of these biomarkers. The development of a multiplex detection platform allows for rapid and sensitive analysis, enabling clinicians to obtain valuable insights into the molecular profile of tumors. This research contributes to the advancement of personalized medicine by facilitating the identification of suitable therapeutic strategies tailored to individual patients based on their specific biomarker profiles.